In-vitro Diagnostic Services Market

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person?s overall health to help cure, treat, or prevent diseases.

In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person?s DNA to detect genomic variations.

Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.

In-vitro Diagnostic Services Market contains market size and forecasts of In-vitro Diagnostic Services in Global, including the following market information:

Global In-vitro Diagnostic Services Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In-vitro Diagnostic Services market was valued at 66330 million in 2021 and is projected to reach US$ 88020 million by 2028, at a CAGR of 4.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Infectious Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In-vitro Diagnostic Services include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics and Siemens, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the In-vitro Diagnostic Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In-vitro Diagnostic Services Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Diagnostic Services Market Segment Percentages, by Type, 2021 (%)

Infectious Testing

Diabetes Testing

Molecular Testing

Tissue Testing

Global In-vitro Diagnostic Services Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Diagnostic Services Market Segment Percentages, by Application, 2021 (%)

Hospitals

Point-Of-Care Testing

Laboratories

Academic Institutes

Global In-vitro Diagnostic Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In-vitro Diagnostic Services Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In-vitro Diagnostic Services revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies In-vitro Diagnostic Services revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

BioRad

DexCom

Nova Biomedical

OraSure

Pearl Pathways

Phenomenex

Qiagen

Roche Diagnostics

Siemens

Sysmex

Thermofisher